SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025133
Filing Date
2020-05-13
Accepted
2020-05-13 17:18:06
Documents
53
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q etnb-10q_20200331.htm 10-Q 2502142
2 EX-10.2 etnb-ex102_184.htm EX-10.2 22747
3 EX-31.1 etnb-ex311_8.htm EX-31.1 17363
4 EX-31.2 etnb-ex312_7.htm EX-31.2 17375
5 EX-32 etnb-ex32_6.htm EX-32 15600
  Complete submission text file 0001564590-20-025133.txt   5225159

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT etnb-20200331.xml EX-101.INS 625867
7 XBRL TAXONOMY EXTENSION SCHEMA etnb-20200331.xsd EX-101.SCH 36470
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE etnb-20200331_cal.xml EX-101.CAL 24363
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE etnb-20200331_def.xml EX-101.DEF 123682
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20200331_lab.xml EX-101.LAB 306825
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20200331_pre.xml EX-101.PRE 231730
Mailing Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105
Business Address 535 MISSION STREET 14TH FLOOR SAN FRANCISCO CA 94105 4155004614
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

IRS No.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39122 | Film No.: 20874213
SIC: 2834 Pharmaceutical Preparations